Precision medicine is an emerging field that looks at how a person’s unique genetic makeup can help determine what treatment might work best for that individual. Although many research studies have shown that precision medicine can lead to better health for some patients, very few of these research studies have looked at precision medicine specifically for African Americans. As a result, we don’t know if African Americans benefit from precision medicine as much as people of European ancestry do.
The African American Cardiovascular Pharmacogenomics Consortium or ACCOuNT is a group of doctors, researchers, community leaders, and patients whose goal is to ensure that all people, including African Americans, benefit fully from precision medicine.
THREE MAIN GOALS
DISCOVERY
Search for genetic variations in African Americans that may affect how a person responds to a medication.
TRANSLATION
Develop recommendations that doctors can use when prescribing medications to African American patients.
DISSEMINATION
Share information about precision medicine and pharmacogenomic research with patients and communities.
LEADERSHIP
Minoli Perera, PharmD, PhD
Principal Investigator
David Meltzer, MD, PhDPrincipal Investigator
Doriane Miller, MD
Core Lead
Robert Grossman, PhD
